Larry D. /fa Horner

Larry D. /fa Horner discloses dealings in 4 companies, chiefly New River Pharmaceuticals Inc, Clinical Data Inc and Precigen, Inc. The record holds 46 filings, for trades running from 20 March 2006 to 12 March 2015.

Both buying and selling appear: 2 purchases worth €238k, against 12 sales worth €6.1M. On balance, insiders were net sellers of €5.8M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 21 share grants and 7 option exercises.

The record was last updated on 23 March 2015 with a share grant (€66k) in Precigen, Inc. The clock since the last published purchase (15 June 2006) now reads 7,436 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.